Mr. Azar spent nearly 10 years at Eli Lilly, including five as president, before leaving in January. "I don't think anybody can question his credentials from an experience perspective". "He promised the American people he would bring skyrocketing drug prices 'way, way, way, down.' But when given the chance to put his money where his mouth is, he brazenly nominated a former pharmaceutical executive to lead the agency charged with managing prescription drug costs".
The resignation of Tom Price was seen as politically expedient after his spurious usage of private and government aircraft over commercial planes caused an uproar and instigated investigations into the wasteful practice. Still, drug pricing talk hasn't gotten serious in Congress and four Congressmen wrote to the president last month to say his "inaction" on their Medicare negotiation proposal has left them with no option other than to press ahead alone. He will be a star for better healthcare and lower drug prices!
Republicans were supportive with Senate health committee head Lamar Alexander of Tennessee describing Azar as a qualified, experienced nominee.
MSU vs. Duke in Champions Classic
Marvin Bagley III reclassified this summer to graduate high school early and begin his college basketball career this season. That being said, Michigan State had a similar dominating start to the season with a 32-point victory over North Florida.
Currently, Azar is the chairman and founder of Seraphim Strategies, which provides strategic consulting and counsel on biopharmaceutical and health insurance industries.
Patient advocacy organization Public Citizen said Azar has made it clear he is opposed to measures "to restrain prescription companies' profiteering and limit improper marketing" and that he favors weaker safety approval standards.
Trump's nomination of Azaro has been met with some scrutiny. He served as the HHS deputy secretary under President George W. Bush.